MedsEngine has filed a notice of an exempt offering of securities to raise $5,795,454.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, MedsEngine is raising up to $5,795,454.00 in new funding. Sources indicate that as part of senior management President, Michael Gearhardt played a key role in…